VECT — VectivBio Holding AG Income Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousMid Cap
- $1.06bn
- $846.20m
Annual income statement for VectivBio Holding AG, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 24.3 | 57.3 | 86.7 | 80.5 |
| Operating Profit | -24.3 | -57.3 | -86.7 | -80.5 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -23.5 | -59.9 | -86.9 | -93.6 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -23.5 | -59.9 | -87 | -93.7 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -23.5 | -59.9 | -87 | -93.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -23.5 | -59.9 | -87 | -93.7 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.69 | -1.76 | -2.37 | -2.12 |
| Dividends per Share |